UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: November 14, 2014
Form: S-3
CIK: 0001140098
Company Name: Ocata Therapeutics, Inc.
File Number: 333-199311